Neurocrine Biosciences (NBIX) Tax Rate (2019 - 2026)

Neurocrine Biosciences has reported Tax Rate for 8 years, with the latest figure at 19.81% in Q1 2026.

• For the quarter ending Q1 2026, Tax Rate fell 2644.0% year-over-year to 19.81%; the trailing twelve-month figure through Mar 2026 stood at 28.68% (down 572.0% YoY), and the FY2025 full-year result was 32.15%, up 238.0% from the prior year.
• Tax Rate for Q1 2026 stood at 19.81%, down from 35.8% in the prior quarter.
• The five-year high for Tax Rate was 46.26% in Q1 2025, with the low at 25.8% in Q1 2024.
• Historically, Tax Rate has averaged 26.9% across 5 years, with a median of 28.2% in 2025.
• Annual changes were most pronounced in 2024 — Tax Rate tumbled 5164 bps — and 2025, when it soared 7206 bps.
• Neurocrine Biosciences' Tax Rate stood at 24.51% in 2022, then climbed by 4 bps to 25.48% in 2023, then surged by 44 bps to 36.59% in 2024, then dropped by 2 bps to 35.8% in 2025, then sank by 45 bps to 19.81% in 2026.
• The last three Tax Rate figures came in at 19.81% (Q1 2026), 35.8% (Q4 2025), and 28.2% (Q3 2025), per Business Quant data.